What if the work you did every day could impact the lives of people you know? Or all of humanity?At Illumina, we are expanding access to genomic technology to realize health equity for billions of people around the world. Our efforts enable life-changing discoveries that are transforming human health through the early detection and diagnosis of diseases and new treatment options for patients.Working at Illumina means being part of something bigger than yourself. Every person, in every role, has the opportunity to make a difference. Surrounded by extraordinary people, inspiring leaders, and world changing projects, you will do more and become more than you ever thought possible.
Reporting directly to the SVP, BioInsight, the Senior Director of Population Genomicsis responsible forestablishing our strategy and leading a team to pursue and deliver large national genomics initiatives (LNGI)This role combines strategic oversight with operational leadership, focusing on building effective partnerships and driving successful outcomes in large-scale population genomics programsIn addition, this leader will inspire, guide, and empower a multidisciplinary team to architect and deliver transformative solutions
As the strategic force behind our population genomics ambitions, you will drive innovation, cultivate partnerships, and position the organization as the trusted partner of choice for governments, health ministries, and national programsYour leadership will unlock new possibilities for genomic medicine at scale, driving both commercial success and societal impact.
Responsibilities
Strategic Leadership & Vision
Set the global vision and strategy for population genomics, anticipating emerging trends and shaping the future of national genomics programs.
Inspire and lead a high-performing team across program management,product management, and product marketing to pursue and win large-scale initiatives.
Develop and continuously refine a global playbook for engaging with national genomics opportunities, ensuring repeatable success and market leadership.
Team Empowerment & Cross-Functional Collaboration
Build, mentor, and empower a multidisciplinary team, fostering a culture of innovation, accountability, and excellence.
Orchestrate cross-functional collaboration with Sales, Development, Medical Affairs, and other internal leaders to deliver integrated, world-class solutions.
Market Engagement & Thought Leadership
Serve as the organization’s ambassador in high-profile forums and conferences, shaping the narrative and advancing the field of population genomics.
Cultivate and nurture strategic relationships with government officials, health system executives, and academic leaders to expand our influence and impact.
Guide the team in developing compelling proposals, leading tender and RFP submissions, and securing multi-year, multi-million-dollar partnerships.
Program Stewardship & Impact
Oversee the successful implementation of national genomics programs, ensuring delivery excellence, stakeholder satisfaction, and measurable impact.
Establish and monitor key performance indicators to demonstrate program success and ROI to partners and internal stakeholders.
Champion ethical, inclusive, and innovative practices that advance health equity and scientific progress.
Qualifications
15+ years of executive-level experience in the genomics industry, or similar
Deep domain knowledge in sequencing technologies, population genomics, and lab operations.
Executive presence and influence, with the ability to engage national health executives and C-suite partners.
Willingness and ability to travel globally (30–50%); role is ideally based in San Diego, with flexibility for exceptional candidates.
Visionary, strategic, and collaborative leader with a passion for driving innovation and impact at scale.
Advanced degree required; PhD preferred, MBA a strong plus.
Experience
Demonstrated success in either securing major LNGI contracts for an organization or in evaluating and selecting winning bids as a LNGI program leader.
Proven ability to apply operational, strategic, and technical expertise to the pursuit and delivery of LNGIs.
Experience leading product management and marketing teams is beneficial, supporting the broader goal of winning and delivering population scale programs, but not required
Deep understanding of what it takes to operate, establish, or lead LNGIs, with the ability to translate this knowledge into successful business development strategies.
Public speaking and executive communication experience at industry conferences, policy forums, and board-level briefings.
The estimated base salary range for the Sr Director, Population Genomics role based in the United States of America is: $224,900 - $337,300. Should the level or location of the role change during the hiring process, the applicable base pay range may be updated accordingly. The range reflects long‑term growth in the role; therefore, most candidates are hired between the minimum and middle of the range. Placement depends on experience, skills, location, and internal equity. Additionally, all employees are eligible for one of our variable cash programs (bonus or commission) and eligible roles may receive equity as part of the compensation package. We offer a wide range of benefits as innovative as our work, including access to genomics sequencing, family planning, health/dental/vision, retirement benefits, and paid time off.
We are a company deeply rooted in belonging, promoting an inclusive environment where employees feel valued and empowered to contribute to our mission. Built on a strong foundation, Illumina has always prioritized openness, collaboration, and seeking alternative perspectives to propel innovation in genomics. We are proud to confirm a zero-net gap in pay, regardless of gender, ethnicity, or race. We also have several Employee Resource Groups (ERG) that deliver career development experiences, increase cultural awareness, and offer opportunities to engage in social responsibility. We are proud to be an equal opportunity employer committed to providing employment opportunity regardless of sex, race, creed, color, gender, religion, marital status, domestic partner status, age, national origin or ancestry, physical or mental disability, medical condition, sexual orientation, pregnancy, military or veteran status, citizenship status, and genetic information. Illumina conducts background checks on applicants for whom a conditional offer of employment has been made. Qualified applicants with arrest or conviction records will be considered for employment in accordance with applicable local, state, and federal laws. Background check results may potentially result in the withdrawal of a conditional offer of employment. The background check process and any decisions made as a result shall be made in accordance with all applicable local, state, and federal laws. Illumina prohibits the use of generative artificial intelligence (AI) in the application and interview process. If you require accommodation to complete the application or interview process, please contact accommodations@illumina.com. To learn more, visit: https://www.dol.gov/ofccp/regs/compliance/posters/pdf/eeopost.pdf. The position will be posted until a final candidate is selected or the requisition has a sufficient number of qualified applicants.
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
